Alnylam Pharmaceuticals, Inc. (ALNY) vs Veeva Systems Inc. (VEEV)
VEEV leads on 8 of 14 compared metrics.
A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Veeva Systems Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
ALNY
Alnylam Pharmaceuticals, Inc.
$280.59HealthcareDelayed quote: Jul 15, 2026, 11:45 AM EDT
VEEV
Veeva Systems Inc.
$195.82HealthcareDelayed quote: Jul 15, 2026, 11:45 AM EDT
Total return — ALNY vs VEEV
growth of $100 · dividends reinvested · last 13yALNY +376.7%VEEV +419.6%VEEV compounded faster
ALNY VEEV
ALNY vs VEEV: by the numbers
- •ALNY is the larger company ($37.46B vs $31.81B market cap).
- •VEEV trades at the lower earnings multiple (34.42 vs 66.81 P/E).
- •VEEV converts more revenue to profit (28.37% vs 13.46% net margin).
- •ALNY grew revenue faster over the past five years (49.67% vs 16.28% CAGR).
Which is better, ALNY or VEEV?
Metric tally: ALNY 6 · VEEV 8It depends on what you're optimizing for:
ValueVEEV(lower P/E)
GrowthALNY(faster 5Y revenue CAGR)
QualityALNY(higher ROIC)
Metrics side by side
Valuation
| Metric | ALNY | VEEV |
|---|---|---|
| P/E ratio | 66.81 | 34.42● |
| Forward P/E | 37.91 | 24.32● |
| P/S ratio | 9.07● | 9.66 |
| P/B ratio | 36.15 | 4.39● |
| PEG ratio | — | 1.42 |
| EV / EBITDA | 47.64 | 29.90● |
| FCF yield | 1.65% | 5.13%● |
Profitability
| Metric | ALNY | VEEV |
|---|---|---|
| Gross margin | 80.89%● | 74.95% |
| Operating margin | 17.54% | 28.79%● |
| Net margin | 13.46% | 28.37%● |
| ROE | 53.68%● | 12.89% |
| ROIC | 13.74%● | 9.48% |
Growth (annualized)
| Metric | ALNY | VEEV |
|---|---|---|
| Revenue CAGR (5Y) | 49.67%● | 16.28% |
| EPS CAGR (5Y) | — | 17.11% |
| FCF CAGR (5Y) | 14.35% | 17.43%● |
| Total return CAGR (5Y) | 10.55%● | -9.33% |
Frequently asked
- Which is better, ALNY or VEEV?
- It depends on your goal. value: VEEV (lower P/E); growth: ALNY (faster 5Y revenue CAGR); quality: ALNY (higher ROIC). Across all compared metrics, VEEV leads 8 to 6.
- Is ALNY or VEEV cheaper?
- On trailing earnings, VEEV is cheaper: ALNY trades at a 66.81 P/E and VEEV at 34.42.
- Which has grown faster, ALNY or VEEV?
- Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus VEEV at 16.28%.
- Is ALNY or VEEV more profitable?
- VEEV runs the higher net margin — ALNY at 13.46% versus VEEV at 28.37%.
- Which has been the better investment, ALNY or VEEV?
- Over the past 10-year, VEEV delivered the higher annualized total return — ALNY at 16.14% versus VEEV at 18.23%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alnylam Pharmaceuticals P/E ratioVeeva Systems P/E ratioAlnylam Pharmaceuticals dividend yieldVeeva Systems dividend yieldAlnylam Pharmaceuticals ROEVeeva Systems ROEAlnylam Pharmaceuticals operating marginVeeva Systems operating marginAlnylam Pharmaceuticals revenue growthVeeva Systems revenue growthAlnylam Pharmaceuticals free cash flowVeeva Systems free cash flow
Alnylam Pharmaceuticals & Veeva Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 15, 2026.